273 online
 
Most Popular Choices
Share on Facebook 67 Printer Friendly Page More Sharing Summarizing
OpEdNews Op Eds   

Will the world leaders walk the talk to end TB at the upcoming UN High Level Meeting?

By       (Page 3 of 3 pages) Become a premium member to see this article and all articles as one long page.   No comments

Citizen News Service - CNS
Follow Me on Twitter     Message Citizen News Service - CNS
Become a Fan
  (2 fans)

Dr Yaacoub also echoes the concern on sustainable financing, equity, and TB risk factors: "UNHLM on TB should put TB on top of the agenda, not only by signing declarations and commitments to support us by developing ambitious strategic plans, but by securing funding for us to implement these plans and to reach our goal of a TB free world. I would ask them to make all the latest TB diagnostics, medications, and prevention tools, including the vaccines (currently under research), accessible and available to all, in all the countries. In addition, I would ask them to secure funding to fight the social determinants of TB, like poverty and malnutrition, that are the real drivers of TB."

Evaline Kibuchi, Chief National Coordinator of Stop TB Partnership Kenya, also echoes the call for a safe and effective TB vaccine that should be rolled out equitably when available.

It's time to deliver on the #endTB promise

The clock is ticking as the goalpost to end TB draws closer. With less than 88 months left to end TB globally, Molbio Diagnostics co-founder and serial entrepreneur Sriram Natarajan hopes from the upcoming UNHLM for stronger commitments to galvanize the fight against TB. "All said and done, lot of people are dying unnecessarily of TB. These lives could be saved just by introducing the right tools timely and effectively," he said.

The cost of inaction (on fully converting scientific breakthroughs into public health impact) is unacceptable. Failure to universally deploy the WHO recommended standard tools for TB diagnostics and treatments result in missed TB cases, avoidable suffering, and untimely deaths. In addition, the failure to break the chain of infection transmission threatens to reverse the gains made in the fight against TB.

Shobha Shukla, Bobby Ramakant - CNS (Citizen News Service)

(Shobha Shukla and Bobby Ramakant are part of the editorial team of CNS (Citizen News Service). Both are on the governing board of Asia Pacific Media Alliance for Health and Development (APCAT Media) and PRB Public Health Reporting Corps. Follow them on Twitter: @Shobha1Shukla, @BobbyRamakant).

- Shared under Creative Commons (CC)

Next Page  1  |  2  |  3

(Note: You can view every article as one long page if you sign up as an Advocate Member, or higher).

Rate It | View Ratings

Citizen News Service - CNS Social Media Pages: Facebook page url on login Profile not filled in       Twitter page url on login Profile not filled in       Linkedin page url on login Profile not filled in       Instagram page url on login Profile not filled in

Citizen News Service (CNS) specializes in in-depth and rights-based, health and science journalism. For more information, please contact: www.citizen-news.org or @cns_health or www.facebook.com/cns.page
Go To Commenting
The views expressed herein are the sole responsibility of the author and do not necessarily reflect those of this website or its editors.
Writers Guidelines

 
Contact AuthorContact Author Contact EditorContact Editor Author PageView Authors' Articles
Support OpEdNews

OpEdNews depends upon can't survive without your help.

If you value this article and the work of OpEdNews, please either Donate or Purchase a premium membership.

STAY IN THE KNOW
If you've enjoyed this, sign up for our daily or weekly newsletter to get lots of great progressive content.
Daily Weekly     OpEd News Newsletter

Name
Email
   (Opens new browser window)
 

Most Popular Articles by this Author:     (View All Most Popular Articles by this Author)

The chasm between TB and HIV continues

Management of respiratory diseases beyond drugs: Pulmonary Rehabilitation

Oxygen therapy is like a prescription drug: Use it rationally

New funding boosts research for controlling TB, malaria, dengue and leishmaniasis

Why are shorter, safer and more effective treatments for drug-resistant TB not being rolled out?

Journey of a TB survivor from pain to strength

To View Comments or Join the Conversation:

Tell A Friend